BBMJ3d agoDetrimental effects of conflicts of interest in GLP-1 therapy guidanceArnav Agarwal·Thomas Agoritsas·Per Olav Vandvik·Nicolas DelvauxRead at BMJTagsPharmaceutical industry and healthcarePharmacology